MICOT PHARMA-B
0233518AListed醫療健康 · 一家专注于代谢及心脑血管疾病的多肽药物研发的生物科技公司。
High attention
78.7
/100
- Offer price
- HK$18.20
- Final offer price
- HK$18.20
- Lot / entry fee
- 200 shares · HK$4K
- Proceeds
- HK$1.06B
- Sponsor
- CCB International / China Merchants Securities
- Est. margin oversub.
- 663.3x
- Public oversub.
- 1181.5x
- One-lot win rate
- 3.0%
- First-day return
- +102.8%
Offer starts
Jun 15
Offer closes
Jun 18
Grey market
Jun 23
Listing
Jun 24
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
78.7/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
PositivePartial basis
Up probability
95.0%
First-day reference range
+71.4% – +158.3%
Published outcome check
First-day resultBig up+102.8%
Our call: Trend call valid
Covered 17/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Weaker qualityCornerstone lockup
Strong supportPost-lockup offer value
Medium scarcityRecent same-rule trend
Strong trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Average appealFundamental quality
Weaker qualityGrowth quality
—Profitability
—Cash runway
Weak qualityCustomer concentration
—Cornerstone quality
Low supportSponsor record
Strong recordGreenshoe arrangementGreenshoe: yes · 15%
Average supportStabilizer track record
—A-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
Good heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.